DD
Highly rated in
61
conditions
Highly rated in
61
conditions
Check Dr. Donald C. Doll's experience treating your condition:
About Dr. Donald C. Doll

Donald Doll is a Hematologist Oncology expert in Columbia, Missouri. Doll has been practicing medicine for over 50 years and is highly rated in 61 conditions, according to our data. His top areas of expertise are Autoimmune Hemolytic Anemia, Glioma, Brain Tumor, Glioblastoma, and Bone Marrow Aspiration. He is licensed to treat patients in Missouri. Doll is currently accepting new patients.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 5 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Donald C. Doll it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Donald C. Doll accepts the following insurance:

  •  Medica
  •  Health Alliance

Call to see if your plan is accepted.
Locations
1 Hospital Dr, Columbia, MO 65212
Background & Education
Graduate Institution
University Of Iowa, Rj & L Carver College Of Medicine, 1972
Specialties
Hematology Oncology
Licenses
Internal Medicine in MO
Hospital Affiliations
University Hospital
Ellis Fischel Cancer Center
Audrain Community Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas
A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
View 4 Less Clinical Trials -

20 Total Publications

A Rare Case of Glioblastoma With Extensive Liver Metastases.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors